Oracle shares slid 9.5% to $182.20 following its earnings report. While the company posted higher profits driven by cloud revenue, a concurrent dip in software sales and the high cost of building artificial intelligence infrastructure signaled potential pressure on near-term margins. Similarly, Oxford Industries saw its stock drop 8.7% to $39.50 as the company pointed to tariff costs and shifting consumer sentiment as primary drags on its bottom line.

Capital raising efforts weighed heavily on smaller firms. Humacyte shares fell 12% to $1.18, despite reporting that its bioengineered blood vessel successfully met primary endpoints in a Phase 3 trial, as the company announced an underwritten public stock offering. PureCycle Technologies experienced a sharper decline of 14% to $8.55 after revealing plans for a $145 million stock offering alongside a $250 million sale of convertible senior notes due in 2032.